According to Spanish sources, the Amavi move has been knocked back after the player failed a medical which showed that the player has a significant risk of the cruciate knee injury that he suffered while playing for France, re-occurring.
Now it’s well known that Sevilla will try any trick in the book to get a player’s price down (and why not? it’s good business sense, something we’ve sorely lacked recently) and if so, you’d hope we’ll give them short shrift and not even entertain the idea of them getting him on a loan or even at cut price.
And indeed “significant risk” is a matter of judgement that might well mean they’re trying it on.
For any expert in any area, you can always find someone who thinks the opposite, after all.
But my worry is what if this is all plausible and Amavi does have that significant risk?
Even though there is supposed to be a fair amount of interest in the player, surely this will see him being valued at a much lower worth?
All in all, this is a fairly big bombshell, as surely we were banking on getting a good few quid for Amavi, which in turn, must have made his sale pivotal to our spending plans?
I don’t want to be the doom-monger that some of you paint me out to be, but the fact is, this could quite easily put paid to any more spending in this window, because if as we suspect, we wanted another two or three players in, the sums are beginning to not add up
You would have to hope that Sevilla are indeed just playing their usual games.
But even then, just the talk of this will surely mean any other interest will wane, at best.
If we were in a better financial position, I’d have liked to see Dr Xia tell Sevilla that we’ll never do business with them again.
The trouble is, I suspect our hand might already have been forced and we’ll have to let him go on the cheap.
It’ll be interesting to see what happens.